LGND Competitors & Alternatives
Compare Ligand Pharmaceuticals Incorporated with similar stocks in the same industry
Biotechnology
LGND
Main Stock$319.55
Tradestie Score
60
Market Cap
$3.49B
P/E Ratio
40.7
Revenue Growth
0.1%
Analyst Upside
-13.1%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 55 | Compare |
|
CYTK
Cytokinetics Inc.
|
$86.49
|
$6.68B | - | 64 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$114.17
|
$6.64B | - | 54 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$144.65
|
$6.38B | - | 59 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$29.91
|
$6.03B | - | 51 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$60.08
|
$6.02B | - | 63 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.73
|
$5.95B | - | 61 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$244.31
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$53.31
|
$5.80B | 18.7 | 55 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$375.07
|
$5.20B | 49.7 | 61 | Compare |
More LGND Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry